VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$0.22
0.00 (-1.70%)
As of Sep 28, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
832.6K
Net Income
-88,006,029
Gross Margin
100.0%
Profit Margin
-10,567.2%
Rev Growth
-29.3%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 100.0% 100.0% 53.9% 53.9%
Operating Margin -10,832.1% -9,748.9% 10.2% 11.9%
Profit Margin -10,567.2% -10,038.8% 12.7% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 832.6K 1.18M 3.56M 2.77M
Gross Profit 832.6K 1.18M 1.92M 1.49M
Operating Income -90,191,631 -114,747,622 363.1K 329.5K
Net Income -88,006,029 -111,966,958 452.9K 261.8K
Gross Margin 100.0% 100.0% 53.9% 53.9%
Operating Margin -10,832.1% -9,748.9% 10.2% 11.9%
Profit Margin -10,567.2% -10,038.8% 12.7% 9.5%
Rev Growth -29.3% -29.3% +0.2% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.21M 2.49M
Total Equity — — 4.37M 4.42M
D/E Ratio — — 0.51 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -88,845,248 -119,314,370 509.0K 375.7K
Free Cash Flow — — 445.4K 284.4K